Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
1.2%
1w
5.3%
1m
9.2%
3m
18.0%
6m
24.5%
1y
41.7%
all
11.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,229 1.2%
1,100
1,530
Company Overview
Sales
1,159 Cr
Growth: 0.2%
Profit after Tax
313 Cr
Growth: -3.5%
Mid Cap
12,857 Cr
P/E: 41.3x
Industry P/E: 29.7x
Fundamentals
Sales (Cr) ₹ 1,159
Growth 0.2%
EBITDA 37.9%
P/S 11.1x
Dividend 0.6%
P/E 41.3x
Book Value ₹ 190
PEG Ratio 175.6x
ROE 16.5%
P/B 6.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (21 Indices) view more
Followers (1)
varsha96